Publication | Open Access
Plasma LDH: A specific biomarker for lung affectation in COVID-19?
28
Citations
12
References
2021
Year
Our findings suggest that elevation of plasma LDH activity in patients with COVID-19 is not associated to a specific release of LDH-3 into the bloodstream, and do not support the use of LDH as a specific biomarker for lung affectation in patients with COVID-19.
| Year | Citations | |
|---|---|---|
Page 1
Page 1